eXalt3: Phase 3 Randomized Study Comparing Ensartinib to Crizotinib in Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer Patients Horn, L., Wu, Y., Reck, M., Wakelee, H., Liang, C., Harrow, K., Oertel, V., Mok, T. ELSEVIER SCIENCE INC. 2018: S582

View details for DOI 10.1016/j.jtho.2018.08.858

View details for Web of Science ID 000454014502014